[Skip to Content]
[Skip to Content Landing]
Article
March 19, 1960

SEX STEROIDS FOR PALLIATION OF DISSEMINATED MAMMARY CARCINOMAGUEST EDITORIAL

Author Affiliations

Chairman, Subcommittee on Breast and Genital Cancer, Committee on Research, Los Angeles.

JAMA. 1960;172(12):1288-1289. doi:10.1001/jama.1960.03020120066012

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

ELSEWHERE in these pages is the final report of a pioneer effort in the pooling of clinical data from a cross-section of investigators in the United States and Canada, the intent of which was to replace confusion with some degree of clarity in a "new" area of cancer therapeusis. Although the use of estrogenic and androgenic hormones for palliation of mammary carcinoma is no longer new, as it was when the Committee on Research initiated this study in 1946, some of the prejudices and mistaken practices current then seem to be almost as prevalent now. The primary benefit of a cooperative study should be an accumulation of comparable data, on samples of significant size, long before the individual investigator or institution can acquire the experience necessary for valid reporting. The Subcommittee on Breast and Genital Cancer, which is responsible for this study, has published various reports; however, the final evaluation

First Page Preview View Large
First page PDF preview
First page PDF preview
×